dipyridamole plus intralesional triamcinolone NL Pages on BioPortfolio:

BioPortfolio - necrobiosis
BioPortfolio - dipyridamole plus intralesional triamcinolone NL BACKGROUND: Cutaneous anaesthesia in necrobiosis lipoidica (NL) has been. ...
http://www.bioportfolio.com/search/necrobiosis.html...

BioPortfolio - Necrobiosis Lipoidica research
AIMS: Necrobiosis lipoidica (NL) is a chronic inflammatory skin disease. ... was successfully treated with dipyridamole plus intralesional triamcinolone. ...
http://www.bioportfolio.com/indepth/Necrobiosis_Lipoidica/re...

BioPortfolio - Necrobiosis Lipoidica - InDepth
successfully treated with dipyridamole plus intralesional triamcinolone. The significance of necrobiosis lipoidica (NL) includes its relationship...27th ...
http://www.bioportfolio.com/indepth/Necrobiosis_Lipoidica.pd...

Results from other life science and pharmaceutical sites:

Necrobiosis lipoidica: a case with histopathologic...[J Dermatolog ...
The patient had suffered persistent NL for a period of more than 2 years. She was successfully treated with dipyridamole plus intralesional triamcinolone ...
http://www.ncbi.nlm.nih.gov/pubmed/18273726...

The Treatment of Necrobiosis Lipoidica
Rather surprisingly, there are very limited data on the benefits or otherwise of corticosteroid therapy in NL. Intralesional triamcinolone has been reported ...
http://www.medscape.com/viewarticle/502353_3...

Persistent ulcerated necrobiosis lipoidica respond...[Br J ...
We report two patients with severe ulcerated necrobiosis lipoidica (NL) who ... was successfully treated with dipyridamole plus intralesional triamcinolone. ...
http://www.ncbi.nlm.nih.gov/pubmed/10583126...

Vital and Health Statistics; Series 2, No. 90 (3/82)
PLUS. 18420. MARFLEX. 60. 18425. MARGESIC. COMPOUND NO. 65. 18430. MARGESIC ...... SK-TRIAMCINOLONE. 28025. SI!4EC0. 28030. SIHETHICONE. 29035. SIHILAC ...
http://www.cdc.gov/nchs/data/series/sr_02/sr02_090.pdf...

092908
692, ABNEU0200, Brain basis of body image in older women, N. L. Tartar Trust Rsch ..... Protocol#2: A Randomized Trial Comparing Intravitreal Triamcinolone
...
http://www.ohsu.edu/research/rda/spa/docs/crosswalk.xls...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.